The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits.
In a Perspective, Jacqueline Deeen discusses challenges in balancing the individual and population risks and benefits for CYD-TDV (Dengvaxia), the first available dengue vaccine.
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-11-01
|
| Series: | PLoS Medicine |
| Online Access: | http://europepmc.org/articles/PMC5127493?pdf=render |